...
首页> 外文期刊>Journal of proteome research >Mass Spectrometric Characterization of the Surface-Associated 42 kDa Lipoprotein JlpA as a Glycosylated Antigen in Strains of Campylobacter jejuni
【24h】

Mass Spectrometric Characterization of the Surface-Associated 42 kDa Lipoprotein JlpA as a Glycosylated Antigen in Strains of Campylobacter jejuni

机译:空化弯曲杆菌菌株中与表面相关的42 kDa脂蛋白JlpA作为糖基化抗原的质谱表征

获取原文
获取原文并翻译 | 示例
           

摘要

Campylobacter jejuni is the most common cause of bacterial gastroenteritis in the developed world. Immunoproteornics highlighted a 42-45 kDa antigen that comigrated on two-dimensional (2-DE) gels with the C. jejuni major outer membrane protein (MOMP). Predictive analysis revealed two candidates for the identity of the antigen, the most likely of which was the surface-associated lipoprotein, JlpA. Recombinant JlpA (rJlpA) reacted with patient sera, confirming that JlpA is antigenic. Polyclonal antibodies raised against rJlpA reacted against 3 JlpA mass variants from multiple C. jejuni. These variants differed by approximately 1.5 kDa, suggesting the presence of the N-linked C. jejuni glycan on two sites. Soybean agglutinin affinity and 2-DE purified 2 JlpA glycoforms (43.5 and 45 kDa). Their identities were confirmed using mass spectrometry following trypsin digest. Glycopeptides within JlpA variants were identified by proteinase-K digestion, graphite micropurification and MS-MS. Sites of glycosylation were confirmed as asparagines 107 and 146, both of which are flanked by the N-linked sequon. Sequence analysis confirmed that the N-146 sequon is conserved in all C. jejuni genomes examined to date, while the N-107 sequon is absent in the reference strain NCTC 11168. Western blotting confirmed the presence of only a single JlpA glycoform in both virulent (0) and avirulent (GS) isolates of NCTC 11168. MS analysis showed that JlpA exists as 3 discrete forms, unmodified, glycosylated at N-146, and glycosylated at both N-146/107, suggesting glycan addition at N-146 is necessary for N-107 glycosylation. Glycine extracts and Western blotting revealed that doubly glycosylated JlpA was the predominant form on the C. jejuni JHH1 surface; however, glycosylation is not required for antigenicity. This is the first study to identify N-linked glycosylation of a surface-exposed C. jejuni virulence factor and to show strain variation in glycosylation sites.
机译:空肠弯曲杆菌是发达国家细菌性肠胃炎的最常见原因。免疫蛋白突出显示了一种42-45 kDa抗原,该抗原在二维(2-DE)凝胶上与空肠弯曲杆菌主要外膜蛋白(MOMP)竞争。预测分析揭示了两个候选抗原的身份,最可能的是与表面相关的脂蛋白JlpA。重组JlpA(rJlpA)与患者血清反应,证实JlpA具有抗原性。针对rJlpA的多克隆抗体与来自多个空肠弯曲菌的3个JlpA质量变体反应。这些变体相差约1.5kDa,表明在两个位点存在N-连接的空肠弯曲杆菌聚糖。大豆凝集素亲和力和2-DE纯化的2种JlpA糖型(43.5和45 kDa)。胰蛋白酶消化后,使用质谱法确认了它们的身份。通过蛋白酶-K消化,石墨微纯化和MS-MS鉴定了JlpA变体中的糖肽。确认糖基化的位点为天冬酰胺107和146,两者均侧接N-连接的序列。序列分析证实,迄今为止,在所有空肠弯曲杆菌基因组中,N-146序列均是保守的,而参考菌株NCTC 11168中则不存在N-107序列。蛋白质印迹法证实,在两种强毒株中仅存在单个JlpA糖型(0)和无毒(GS)分离物的NCTC11168。MS分析表明,JlpA以3种离散形式存在,未修饰,在N-146处糖基化,在N-146 / 107处糖基化,表明在N-146处添加了聚糖N-107糖基化所必需。甘氨酸提取物和蛋白质印迹表明,双糖基化的JlpA是空肠弯曲杆菌JHH1表面上的主要形式。但是,抗原性不需要糖基化。这是鉴定表面暴露的空肠弯曲杆菌毒力因子的N联糖基化并显示其糖基化位点变异的第一项研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号